Literature DB >> 10463276

Metabolic and molecular bases of Menkes disease and occipital horn syndrome.

S G Kaler1.   

Abstract

Menkes disease and occipital horn syndrome (OHS) are related disorders of copper transport that involve abnormal neurodevelopment, connective tissue problems, and often premature death. Location of the gene responsible for these conditions on the X chromosome was indicated by pedigree analysis from the time of these syndromes' earliest descriptions. Characterization of an affected female with an X-autosomal translocation was used to identify the Menkes/OHS gene, which encodes a highly evolutionarily conserved, copper-transporting P-type ATPase. The gene normally is expressed in nearly all human tissues, and it localizes to the trans-Golgi network of cells. However, in over 70% of Menkes and OHS patients studied, expression of this gene has been demonstrated to be abnormal. Major gene deletions detectable by Southern blotting account for 15-20% of patients, and an interesting spectrum of other mutations is evident among 58 families whose precise molecular defects have been reported as of this writing. The center region of the gene seems particularly prone to mutation, and those that influence mRNA processing and splicing appear to be relatively common. Further advances in understanding the molecular and cell biological mechanisms involved in normal copper transport may ultimately yield new and better approaches to the management of these disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10463276     DOI: 10.1007/s100249900011

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  34 in total

1.  Mutation in the ATP7A gene may not be responsible for hypocupraemia in copper deficiency myelopathy.

Authors:  N Kumar; J B Gross
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

2.  A novel frameshift mutation in exon 23 of ATP7A (MNK) results in occipital horn syndrome and not in Menkes disease.

Authors:  S L Dagenais; A N Adam; J W Innis; T W Glover
Journal:  Am J Hum Genet       Date:  2001-06-26       Impact factor: 11.025

Review 3.  ATP7A-related copper transport diseases-emerging concepts and future trends.

Authors:  Stephen G Kaler
Journal:  Nat Rev Neurol       Date:  2011-01       Impact factor: 42.937

Review 4.  Classification and differential diagnosis of Wilson's disease.

Authors:  Wieland Hermann
Journal:  Ann Transl Med       Date:  2019-04

5.  Pamidronate treatment improves bone mineral density in children with Menkes disease.

Authors:  S Kanumakala; A Boneh; M Zacharin
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

Review 6.  Inborn errors of copper metabolism.

Authors:  Stephen G Kaler
Journal:  Handb Clin Neurol       Date:  2013

7.  The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.

Authors:  Nataliya V Dolgova; Doug Olson; Svetlana Lutsenko; Oleg Y Dmitriev
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

Review 8.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

9.  Localization of the Wilson disease protein in murine intestine.

Authors:  Karl Heinz Weiss; Judith Wurz; Daniel Gotthardt; Uta Merle; Wolfgang Stremmel; Joachim Füllekrug
Journal:  J Anat       Date:  2008-07-25       Impact factor: 2.610

10.  Copper transport into the secretory pathway is regulated by oxygen in macrophages.

Authors:  Carine White; Taiho Kambe; Yan G Fulcher; Sherri W Sachdev; Ashley I Bush; Kevin Fritsche; Jaekwon Lee; Thomas P Quinn; Michael J Petris
Journal:  J Cell Sci       Date:  2009-04-07       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.